Program EpiNantes 2018

IRS-UN, 8 quai Moncousu Nantes


Jean-Pierre Issa  : Fels Institute for Cancer Research and Molecular Biology, Temple University, Philadelphia, USA

Keynote lecture - Epigenetic therapy : bench to bedside

Silvia Anna Ciafrè  : University of Rome, Italy

Long noncoding RNAs as powerful players in glioblastoma

Yegor Vassetzky : Institut Gustave Roussy, Villejuif, France

Viral proteins: epigenetic effectors of lymphomagenesis

Slimane Ait-si-ali : Epigénétique et destin cellulaire, Paris, France

Genomic and non-genomic roles of mammalian « histone » lysine methyltransferases during cell fate changes

Valentina Boeva  : Computational (Epi-)Genetics of Cancer, Paris, France

Getting insights into neuroblastoma biology using computational analysis of histone modifications

Anaïs Bardet : Epigenetic regulation of cell identity, Illkirch, France

Transcription factor sensitivity to DNA methylation

Jorg Tost : Epigenetics and Environment (LEE), Paris, France

The impact of the environment and epignentics on inflammatory and  autoimmune diseases

Dominique Guianvarc'h : Institut de Chimie Moléculaire et des Matériaux d'Orsay, Paris, France

Chemical tools for studying DNA and histone methylation

Lucia Altucci : Second University of Naples, Italy

Brd9 is critical in acute myeloid leukemia.

Sophie Lelièvre : Purdue University, IBCN, West Lafayette, USA

Risks-on-a-chip to determine the epigenetic effect of mediators of oxidative stress on the breast epithelium.

Pernette Verschure : Synthetic Systems Biology and Nuclear Organization, Amsterdam, The Nederlands

Dynamic epigenetic regulation: Single cells can make the difference

Marco Tomasetti : Department of Clinical and Molecular Sciences, Polytechnic University of Marche, Ancona, Italy

MiR-126 as epigenetic biomarker: from exposure to cancer development

Maria Gazouli : National & Kapodistrian University of Athens, Greece

Methylation Profiles of Cancer-related Genes at Circulating Tumor Cells Population: Implications in prognosis and diagnosis


Antonello Mai : Dipartimento di Chimica e Tecnologiedel Farmaco "Sapienza", Rome, Italy

Up and down in histone methylation: identification of first-in-class dual G9a/LSD1 inhibitors

Saulius Klimašauskas : Life Sciences Center, Vilnius University, Lithuania

Chemo-Enzymatic Approaches for Epigenomic Profiling of DNA

Manfred Jung : Institute of Pharmaceutical Sciences, Universität Freiburg, Germany

Chemical tools to interrogate reversible lysine acylation and methylation

Arasu Ganesan :  University of East Anglia, Norwich Research Park, United Kingdom

What are HDAC inhibitors good for beyond t cell lymphomaµ?